NDC 68462-828
Icatibant
Icatibant Acetate
Icatibant is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., Usa. The primary component is Icatibant Acetate.
| Product ID | 68462-828_8d6e2f8a-884d-48eb-b95f-f74d5ddd6c65 |
| NDC | 68462-828 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Icatibant |
| Generic Name | Icatibant Acetate |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2021-05-21 |
| Marketing Category | ANDA / |
| Application Number | ANDA213222 |
| Labeler Name | GLENMARK PHARMACEUTICALS INC., USA |
| Substance Name | ICATIBANT ACETATE |
| Active Ingredient Strength | 30 mg/3mL |
| Pharm Classes | Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |